Ginsenoside Rg1 relieves rat intervertebral disc degeneration and inhibits IL-1β-induced nucleus pulposus cell apoptosis and inflammation via NF-κB signaling pathway
Aggrecan
Intervertebral Disc
MMP3
Ginsenoside Rg1
Intraperitoneal injection
Matrix Metalloproteinase 3
DOI:
10.1007/s11626-024-00883-6
Publication Date:
2024-03-14T17:02:03Z
AUTHORS (7)
ABSTRACT
Abstract The study aimed to investigate the effect of ginsenoside Rg1 on intervertebral disc degeneration (IVDD) in rats and IL-1β-induced nucleus pulposus (NP) cells, explore its underlying mechanism. Forty IVDD rat models were divided into group, low-dose (L-Rg1) group (intraperitoneal injection 20 mg/kg/d Rg1), medium-dose (M-Rg1) 40 high-dose (H-Rg1) 80 Rg1). pathological change was observed by HE safranin O-fast green staining. expression IL-1β, IL-6, TNF-α, MMP3, aggrecan, collagen II detected. NF-κB p65 IVD tissues Rat NP cells induced IL-1β simulate environment control 20, 50, 100 µmol/L groups. cell proliferation activity, apoptosis, II, pathway–related protein In rats, improved pathology tissues; suppressed II; inhibited p-p65/p65 nuclear translocation p65, alleviate progression. also apoptosis p-p65/p65, IκK a dose-dependent manner. Ginsenoside alleviated inflammatory response, ECM degradation cells. And may exert via inhibiting activation signaling pathway.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (35)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....